Lipocine Announces Multiple Poster Presentations at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021
- Monday, November 1, 2021, 7:13
- Finance
- Add a comment
SALT LAKE CITY, Nov. 1, 2021 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that three abstracts have been selected for poster presentations during the upcoming The Liver Meeting® 2021,…
About the Author
adminasapcorp has written 39042 stories on this site.